These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 34344728)

  • 21. COVID-19 vaccines for children in LMICs: another equity issue.
    Kampmann B; Okomo U
    Lancet; 2021 Aug; 398(10302):731-732. PubMed ID: 34339625
    [No Abstract]   [Full Text] [Related]  

  • 22. A Global Intellectual Property Waiver is Still Needed to Address the Inequities of COVID-19 and Future Pandemic Preparedness.
    Amin T; Kesselheim AS
    Inquiry; 2022; 59():469580221124821. PubMed ID: 36124939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional vaccine production is key to ensuring equity.
    Mendis S
    BMJ; 2021 Sep; 374():n2354. PubMed ID: 34583925
    [No Abstract]   [Full Text] [Related]  

  • 24. Allocating a COVID-19 Vaccine: Balancing National and International Responsibilities.
    Lie RK; Miller FG
    Milbank Q; 2021 Jun; 99(2):450-466. PubMed ID: 33295679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pandemics, intellectual property and 'our economy': A worldview analysis of Canada's role in compromising global access to COVID-19 vaccines.
    Brisbois B; Plamondon K; Walugembe D; Pereira RC; Edet C; Dixon J; Habibi R; Karamouzian M; Labonté R; Murthy S; Ravitsky V
    Glob Public Health; 2024 Jan; 19(1):2335360. PubMed ID: 38626321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maintaining a Focus on Health Equity During the COVID-19 Vaccine Rollout.
    Martin EG; Birkhead GS; Holtgrave DR
    J Public Health Manag Pract; 2021 May-Jun 01; 27(3):226-228. PubMed ID: 33762538
    [No Abstract]   [Full Text] [Related]  

  • 27. Designing the global vaccine supply chain: balancing intellectual property rights with post COVID-19 vaccine equity.
    Park SP; Lee HJ; Yu Y; Lee EYJ; Park YS
    BMJ Glob Health; 2023 Nov; 8(11):. PubMed ID: 38035734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Audio Interview: Vaccine Successes and Vaccine Adverse Events.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Apr; 384(15):e70. PubMed ID: 33852785
    [No Abstract]   [Full Text] [Related]  

  • 29. Centring equity over exceptionalism in the global covid-19 response.
    Chebly KO
    BMJ; 2022 Jan; 376():o20. PubMed ID: 34992066
    [No Abstract]   [Full Text] [Related]  

  • 30. Don't worry about the drug industry's profits when considering a waiver on covid-19 intellectual property rights.
    Hawksbee L; McKee M; King L
    BMJ; 2022 Jan; 376():e067367. PubMed ID: 35101900
    [No Abstract]   [Full Text] [Related]  

  • 31. A step backwards in the fight against global vaccine inequities.
    Aryeetey E; Engebretsen E; Gornitzka Å; Maassen P; Stølen S
    Lancet; 2021 Jan; 397(10268):23-24. PubMed ID: 33308424
    [No Abstract]   [Full Text] [Related]  

  • 32. Covid-19, equity, and inclusiveness.
    Evans NG; Berger ZD; Phelan AL; Silverman RD
    BMJ; 2021 Jun; 373():n1631. PubMed ID: 34187843
    [No Abstract]   [Full Text] [Related]  

  • 33. Recalling the universal health coverage vision and equity in the COVID-19 vaccine distribution plan.
    Adejumo OA; Adejumo OA
    Pan Afr Med J; 2021; 39():197. PubMed ID: 34603578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Why a pioneering plan to distribute COVID vaccines equitably must succeed.
    Nature; 2021 Jan; 589(7841):170. PubMed ID: 33442047
    [No Abstract]   [Full Text] [Related]  

  • 35. To curb COVID-19, global health must go local.
    Nat Med; 2021 Jun; 27(6):929. PubMed ID: 34031608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of the proposed intellectual property waiver as a mechanism to address the COVID-19 vaccine scarcity problem.
    Barnes-Weise J; Santos Rutschman A; Adler R
    J Epidemiol Community Health; 2022 Apr; 76(4):317-318. PubMed ID: 35140119
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of Health Equity in COVID-19 Vaccine Distribution Plans in the United States.
    Hardeman A; Wong T; Denson JL; Postelnicu R; Rojas JC
    JAMA Netw Open; 2021 Jul; 4(7):e2115653. PubMed ID: 34213561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suspend intellectual property rights for covid-19 vaccines.
    Krishtel P; Malpani R
    BMJ; 2021 May; 373():n1344. PubMed ID: 34049897
    [No Abstract]   [Full Text] [Related]  

  • 39. A 7-Point Action Agenda to End the COVID-19 Pandemic for President-elect Biden.
    Gostin LO
    JAMA; 2021 Jan; 325(1):17-18. PubMed ID: 33399836
    [No Abstract]   [Full Text] [Related]  

  • 40. Global South cannot just live with COVID-19.
    Sow SO
    Nat Hum Behav; 2022 Feb; 6(2):170. PubMed ID: 35102354
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.